• Verzenio® abemaciclib tablets 50 | 100 | 150 | 200 mg

    Verzenio is treating more women than ever before Verzenio is approved for women with HR+, HER2–, node-positive early breast cancer with a high risk of returning, as determined by a doctor, or certain types of HR+, HER2– metastatic breast cancer. Early Breast Cancer (EBC) Verzenio is a prescription medicine used in combination with endocrine (hormone)

  • Retevmo® selpercatinib tablets 40 | 80 | 120 | 160 mg (60)

    Retevmo is a targeted therapy you can take at home With Retevmo, it’s time to reimagine tomorrow The first FDA-approved treatment for people with RET-positive advanced non-small cell lung cancer (NSCLC), thyroid cancers, and certain other cancers. Retevmo may affect both healthy cells and tumor cells, which can result in side effects, some of which can

  • Jaypirca® pirtobrutinib tablets 50 | 100 mg (60 tablets)

    Mantle cell lymphoma (MCL) that has come back or did not respond to previous treatment and who have already received at least 2 treatments for their cancer, including a Bruton tyrosine kinase (BTK) inhibitor medicine.Jaypirca was approved for this indication based on how many people responded to treatment. Studies are ongoing to confirm the benefit of

  • Inluriyo™ imlunestrant 200 mg (28 tablets)

    Inluriyo is an oral treatment designed* for ER+, HER2–, ESR1-mutated metastatic breast cancer. Inluriyo is a prescription medicine used to treat adults with advanced breast cancer or breast cancer that has spread to other parts of the body (metastatic) whose disease was previously treated with endocrine therapy. The breast cancer must be ER+, HER2–, and ESR1-mutated. Your healthcare

  • Erbitux® cetuximab injection 100 mg/50 mL, 200 mg/100 mL

    Treatment with ERBITUX and what to expect ERBITUX is an approved treatment for people with certain advanced colorectal and head and neck cancers. Knowing more about your treatment may help you feel more prepared. Here you’ll find information on how your treatment will be given, possible side effects, and helpful tips you can discuss with

  • Cyramza® ramucirumab injection 10 mg/mL solution

    SAFETY SUMMARY Warnings – Serious side effects include: Severe bleeding, including bleeding in the stomach or bowel, has happened with CYRAMZA. This can be life threatening. If severe bleeding happens, you will have to stop receiving CYRAMZA. Tears in the stomach or bowel wall may happen with CYRAMZA. This can be life threatening. If you

  • Alimta® pemetrexed injection 500 mg

    ALIMTA® (uh-LIM-tuh) (pemetrexed for injection) for Intravenous Use What is ALIMTA? ALIMTA is a prescription medicine used to treat: a kind of lung cancer called non-squamous non-small cell lung cancer (NSCLC). ALIMTA is used: as the first treatment in combination with pembrolizumab and platinum chemotherapy when your lung cancer with no abnormal EGFR or ALK gene has

  • Alimta® pemetrexed injection 100 mg

    ALIMTA® (uh-LIM-tuh) (pemetrexed for injection) for Intravenous Use What is ALIMTA? ALIMTA is a prescription medicine used to treat: a kind of lung cancer called non-squamous non-small cell lung cancer (NSCLC). ALIMTA is used: as the first treatment in combination with pembrolizumab and platinum chemotherapy when your lung cancer with no abnormal EGFR or ALK gene has